Paul Weiss, Goodwin Steer Eli Lilly's $2.4B Orna Buy

By Jade Martinez-Pogue · February 9, 2026, 2:17 PM EST

Pharmaceutical giant Eli Lilly & Co., advised by Paul Weiss Rifkind Wharton & Garrison LLP, on Monday announced that it has agreed to buy Goodwin Procter LLP-led biotechnology firm Orna Therapeutics...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login